These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9309120)

  • 1. Frequent allelic losses of 9p21 markers and low incidence of mutations at p16(CDKN2) gene in non-Hodgkin lymphomas of B-cell lineage.
    Fernández-Piqueras J; Santos J; Pérez de Castro I; Meléndez B; Martínez B; Robledo M; Rivas C; Benítez J
    Cancer Genet Cytogenet; 1997 Oct; 98(1):63-8. PubMed ID: 9309120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion mapping of chromosome region 9p21-p22 surrounding the CDKN2 locus in melanoma.
    Ohta M; Berd D; Shimizu M; Nagai H; Cotticelli M-G ; Mastrangelo M; Shields JA; Shields CL; Croce CM; Huebner K
    Int J Cancer; 1996 Mar; 65(6):762-7. PubMed ID: 8631588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome 9p allelic loss and p16/CDKN2 in breast cancer and evidence of p16 inactivation in immortal breast epithelial cells.
    Brenner AJ; Aldaz CM
    Cancer Res; 1995 Jul; 55(13):2892-5. PubMed ID: 7796417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus.
    Barrett MT; Sanchez CA; Galipeau PC; Neshat K; Emond M; Reid BJ
    Oncogene; 1996 Nov; 13(9):1867-73. PubMed ID: 8934532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LOH and mutation analysis of CDKN2 in primary human ovarian cancers.
    Campbell IG; Foulkes WD; Beynon G; Davis M; Englefield P
    Int J Cancer; 1995 Oct; 63(2):222-5. PubMed ID: 7591208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of CDKN2 (p16) in non-small cell lung cancer.
    de Vos S; Miller CW; Takeuchi S; Gombart AF; Cho SK; Koeffler HP
    Genes Chromosomes Cancer; 1995 Nov; 14(3):164-70. PubMed ID: 8589032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational analysis of the CDKN2 (MTS1/p16ink4A) gene in primary B-cell lymphomas.
    Uchida T; Watanabe T; Kinoshita T; Murate T; Saito H; Hotta T
    Blood; 1995 Oct; 86(7):2724-31. PubMed ID: 7670111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2.
    Schultz DC; Vanderveer L; Buetow KH; Boente MP; Ozols RF; Hamilton TC; Godwin AK
    Cancer Res; 1995 May; 55(10):2150-7. PubMed ID: 7743516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
    Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
    J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletional, mutational, and methylation analyses of CDKN2 (p16/MTS1) in primary and metastatic prostate cancer.
    Jarrard DF; Bova GS; Ewing CM; Pin SS; Nguyen SH; Baylin SB; Cairns P; Sidransky D; Herman JG; Isaacs WB
    Genes Chromosomes Cancer; 1997 Jun; 19(2):90-6. PubMed ID: 9171999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low frequency of CDKN2 mutation in endometrial carcinomas.
    Peiffer SL; Bartsch D; Whelan AJ; Mutch DG; Herzog TJ; Goodfellow PJ
    Mol Carcinog; 1995 Aug; 13(4):210-2. PubMed ID: 7646759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The multiple tumor suppressor 1/cyclin-dependent kinase inhibitor 2 gene in human central nervous system primitive neuroectodermal tumor.
    Raffel C; Ueki K; Harsh GR; Louis DN
    Neurosurgery; 1995 May; 36(5):971-4; discussion 974-5. PubMed ID: 7791990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity on chromosome 9 and p16 (MTS1, CDKN2) gene mutations in esophageal cancers.
    Muzeau F; Fléjou JF; Thomas G; Hamelin R
    Int J Cancer; 1997 Jul; 72(1):27-30. PubMed ID: 9212218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDKN2 (MTS1) tumor suppressor gene mutations in human tumor cell lines.
    Liu Q; Neuhausen S; McClure M; Frye C; Weaver-Feldhaus J; Gruis NA; Eddington K; Allalunis-Turner MJ; Skolnick MH; Fujimura FK
    Oncogene; 1995 Mar; 10(6):1061-7. PubMed ID: 7700630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of p16-pRb pathway and chromosome locus 9p21-22 in sporadic invasive breast carcinomas.
    Gorgoulis VG; Koutroumbi EN; Kotsinas A; Zacharatos P; Markopoulos C; Giannikos L; Kyriakou V; Voulgaris Z; Gogas I; Kittas C
    Mol Med; 1998 Dec; 4(12):807-22. PubMed ID: 9990866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion map of chromosome 9 and p16 (CDKN2A) gene alterations in neuroblastoma.
    Takita J; Hayashi Y; Kohno T; Yamaguchi N; Hanada R; Yamamoto K; Yokota J
    Cancer Res; 1997 Mar; 57(5):907-12. PubMed ID: 9041193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MTS1/CDKN2 gene mutations are rare in primary human astrocytomas with allelic loss of chromosome 9p.
    Ueki K; Rubio MP; Ramesh V; Correa KM; Rutter JL; von Deimling A; Buckler AJ; Gusella JF; Louis DN
    Hum Mol Genet; 1994 Oct; 3(10):1841-5. PubMed ID: 7849711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allelotype analysis in mouse hepatocellular carcinomas; frequent homozygous deletion of mouse homolog of p16/CDKN2 gene on chromosome 4 in culture.
    Miyasaka K; Fukui T; Kitagawa T
    Biol Pharm Bull; 1996 May; 19(5):683-91. PubMed ID: 8741575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers.
    Yoshida S; Todoroki T; Ichikawa Y; Hanai S; Suzuki H; Hori M; Fukao K; Miwa M; Uchida K
    Cancer Res; 1995 Jul; 55(13):2756-60. PubMed ID: 7796400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MTS1/p16/CDKN2 lesions in primary glioblastoma multiforme.
    Moulton T; Samara G; Chung WY; Yuan L; Desai R; Sisti M; Bruce J; Tycko B
    Am J Pathol; 1995 Mar; 146(3):613-9. PubMed ID: 7887443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.